These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22340338)

  • 1. Intermittent hypoxia and isoniazid plus rifampicin affect hepatic ultrastructure in mice.
    Wu RH; Zeng YM; Chen XY
    Chin Med J (Engl); 2011 Dec; 124(23):4034-8. PubMed ID: 22340338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
    Chen X; Xu J; Zhang C; Yu T; Wang H; Zhao M; Duan ZH; Zhang Y; Xu JM; Xu DX
    Eur J Pharmacol; 2011 May; 659(1):53-60. PubMed ID: 21419764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental research on chronic intermittent hypoxia leading to liver injury.
    Feng SZ; Tian JL; Zhang Q; Wang H; Sun N; Zhang Y; Chen BY
    Sleep Breath; 2011 Sep; 15(3):493-502. PubMed ID: 20582634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gatifloxacin in combination with rifampicin in a murine tuberculosis model.
    Cynamon M; Sklaney MR; Shoen C
    J Antimicrob Chemother; 2007 Aug; 60(2):429-32. PubMed ID: 17561504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Damage of Inner Ear Sensory Hair Cells via Mitochondrial Loss in a Murine Model of Sleep Apnea With Chronic Intermittent Hypoxia.
    Seo YJ; Ju HM; Lee SH; Kwak SH; Kang MJ; Yoon JH; Kim CH; Cho HJ
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.
    Wang W; Song A; Zeng Y; Chen X; Zhang Y; Shi Y; Lin Y; Luo W
    BMC Cardiovasc Disord; 2018 Jul; 18(1):133. PubMed ID: 29969996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sagittaria sagittifolia polysaccharide protects against isoniazid- and rifampicin-induced hepatic injury via activation of nuclear factor E2-related factor 2 signaling in mice.
    Wang J; Luo W; Li B; Lv J; Ke X; Ge D; Dong R; Wang C; Han Y; Zhang C; Yu H; Liao Y
    J Ethnopharmacol; 2018 Dec; 227():237-245. PubMed ID: 30194055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
    Dickinson JM; Mitchison DA
    Tubercle; 1976 Dec; 57(4):251-8. PubMed ID: 827836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The organ specificity in pathological damage of chronic intermittent hypoxia: an experimental study on rat with high-fat diet.
    Wang H; Tian JL; Feng SZ; Sun N; Chen BY; Zhang Y
    Sleep Breath; 2013 Sep; 17(3):957-65. PubMed ID: 23114729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.
    Kradolfer F; Schnell R
    Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315
    [No Abstract]   [Full Text] [Related]  

  • 12. Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury.
    Wang C; Fan RQ; Zhang YX; Nie H; Li K
    World J Gastroenterol; 2016 Nov; 22(44):9775-9783. PubMed ID: 27956801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy.
    Acocella G; Luisetti M; Grassi GG; Peona V; Pozzi E; Grassi C
    Monaldi Arch Chest Dis; 1993; 48(3):205-9. PubMed ID: 8369784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
    Girling DJ
    Tubercle; 1978 Mar; 59(1):13-32. PubMed ID: 345572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rifampicin and isoniazid on liver function.
    Lal S; Singhal SN; Burley DM; Crossley G
    Br Med J; 1972 Jan; 1(5793):148-50. PubMed ID: 5007842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic intermittent hypoxia preserves bone density in a mouse model of sleep apnea.
    Torres M; Montserrat JM; Pavía J; Dalmases M; Ros D; Fernandez Y; Barbé F; Navajas D; Farré R
    Respir Physiol Neurobiol; 2013 Dec; 189(3):646-8. PubMed ID: 23994179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep apnea hypopnea syndrome and liver injury.
    Tian JL; Zhang Y; Chen BY
    Chin Med J (Engl); 2010 Jan; 123(1):89-94. PubMed ID: 20137582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage.
    Enriquez-Cortina C; Almonte-Becerril M; Clavijo-Cornejo D; Palestino-Domínguez M; Bello-Monroy O; Nuño N; López A; Bucio L; Souza V; Hernández-Pando R; Muñoz L; Gutiérrez-Ruiz MC; Gómez-Quiroz LE
    Toxicol Sci; 2013 Sep; 135(1):26-36. PubMed ID: 23764483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic tolerance in man of rifampicin-isoniazid association].
    Toulet J; Plomteux G; Viteau JM; Abiven M; Bonfante N
    J Med Liban; 1971; 24(6):651-8. PubMed ID: 5146848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.